Retour
Prix Mymetics Corp (MYMX)
Graphique du cours de l'action MYMX
MYMX Gagner
Mymetics Corp
$0
0%
$0
À la fermeture : Feb 06, 16:00:00 GMT-5
$0
0%
$0
Post-Marché: Feb 06, 20:00:00 GMT-5
Pas encore de donnéesEarnings FAQ
Comment le bénéfice par action récent de MYMX se compare-t-il aux attentes ?
Comment les revenus de Mymetics Corp MYMX se sont-ils comportés au dernier trimestre ?
Quelle est l'estimation des revenus pour Mymetics Corp ?
Quel est le score de qualité des bénéfices pour Mymetics Corp ?
Quand Mymetics Corp publie-t-elle ses résultats ?
Quels sont les bénéfices attendus de Mymetics Corp ?
Mymetics Corp a-t-elle dépassé les attentes en matière de bénéfices ?
Statistiques clés
Clôture préc.
$0.0003
Prix d'ouverture
$0.0003
Plage de la journée
$0.0003 - $0.0003
Plage de 52 semaines
$0.0003 - $0.001
Volume
100
Volume moyen
2
BPA (TTM)
-70.19
Rendement en dividend
--
Capitalisation boursière
$44.99999999999999
Qu’est-ce que MYMX ?
Mymetics Corp. is a vaccine company, which focuses on the research and development of next generation vaccines for infectious and life disabling diseases. The company is headquartered in Epalinges, Vaud and currently employs 8 full-time employees. The firm is focused on developing vaccines for infectious diseases. The firm has over five vaccine candidates in its pipeline: human immunodeficiency virus type 1 (HIV-1)/acquired immune deficiency syndrome (AIDS), intra nasal Influenza, Malaria, Herpes Simplex Virus (HSV) and the Respiratory Syncitial Virus (RSV) vaccine. Its technology utilizes virosomes, lipid-based carriers containing functional fusion viral proteins and natural membrane proteins, in combination with rationally designed antigens. Its prophylactic HIV-1 vaccine candidate is constituted of virosomes linked to conserved antigens derived from the HIV-1 glycoprotein 41 (gp41) proteins from the clade B. The RSV vaccine consists of the reconstituted membrane of RSV containing the native viral proteins. The HSV vaccine candidate consists of the reconstituted membrane of HSV-1 or HSV-2. The intranasal influenza vaccine includes the reconstituted membrane of influenza virus.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved